Home > Healthcare > Biotechnology > Bioservices > Downstream Processing Market

Downstream Processing Market Share

Report ID: GMI6479
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Downstream Processing Market Share

The key companies in the downstream processing market are:

Thermo Fisher Scientific Inc.
GE Healthcare
Sartorius Stedim Biotech S.A
Danaher Corporation
Merck and Co. Inc.
3M Company
Boehringer Ingelheim International GmbH,
Lonza Group Ltd.
Eppendorf AG
Repligen Corporation.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of downstream processing recorded USD 11.7 billion in 2023 and is set to reach USD 28.8 billion by 2032, driven by factors such as growing demand for biopharmaceuticals, and rise in the prominence of contract manufacturing organizations (CMOs).

In 2022, the monoclonal antibody production segment held significant market share of 42.6% and is expected to cross USD 25.9 billion by 2032. Downstream processing offers several advantages that impacts the quality, efficiency, and success of the manufacturing process.

North America market value is poised to surpass USD 28.8 billion by 2032, as the region has highly advance healthcare infrastructure with well-established pharmaceutical and biotechnology companies.

Thermo Fisher Scientific Inc., GE Healthcare, Sartorius Stedim Biotech S.A, Danaher Corporation, Merck and Co. Inc., 3M Company, Boehringer Ingelheim International GmbH, Lonza Group Ltd., Eppendorf AG, and Repligen Corporation.